PLPeter Lukac

Peter Lukac

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter Lukac has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Peter S. Hansen

    From the Department of Cardiology (N.M.S.d.G., N.A.B., J.P.v.K., M.J.S.), Leiden University Medical Center, Leiden, The Netherlands; the Department of Cardiology (P.L.), Aarhus University Hospital at Skejby, Aarhus, Denmark; the Department of Cardiology (A.K.P., P.S.H.), Varde Heart Center Varde, Denmark; and the Department of Cardiology (E.D.), Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland

    7 shared publications
  • Anders K. Pedersen

    From the Department of Cardiology (N.M.S.d.G., N.A.B., J.P.v.K., M.J.S.), Leiden University Medical Center, Leiden, The Netherlands; the Department of Cardiology (P.L.), Aarhus University Hospital at Skejby, Aarhus, Denmark; the Department of Cardiology (A.K.P., P.S.H.), Varde Heart Center Varde, Denmark; and the Department of Cardiology (E.D.), Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland

    6 shared publications
  • Vibeke Elisabeth Hjortdal

    Department of Cardiothoracic Surgery Copenhagen University Hospital Copenhagen Denmark

    6 shared publications
  • Henrik Kjærulf Jensen

    Aarhus University Hospital

    5 shared publications
  • Peter T. Mortensen

    Department of Cardiology, Skejby University Hospital, Aarhus, Denmark

    5 shared publications
  • Etienne Delacrétaz

    Swiss Cardiovascular Center Bern , University Hospital , CH-3010 Bern , Switzerland

    1 shared publication

Latest Publications

  • Open Access

    Long-Term Outcome of Ablative Therapy of Postoperative Supraventricular Tachycardias in Patients With Univentricular Heart

    by Natasja M.S. de Groot, Peter Lukac, Nico A. Blom, Jan Peter van Kuijk, Anders K. Pedersen, Peter S. Hansen, Etienne Delacretaz, Martin J. Schalij

    Background— Catheter ablation has evolved as a possible curative treatment modality for supraventricular tachycardias (SVT) in patients with univentricular heart. However, the long-term outcome of ablation procedures is unknown. We evaluated the procedural and long-term outcome of ablative therapy of late postoperative SVT in patients with univentricular heart. Methods and Results— Patients with univentricular heart (n=19, 11 male; age, 29�9 years) referred for ablation of SVT were studied. Ablation was guided by 3D electroanatomic mapping in all but 2 procedures. A total of 41 SVT were diagnosed as intra-atrial reentrant tachycardia (n=30; cycle length, 310�68 ms), typical atrial flutter (n=4; cycle length, 288�42 ms), focal atrial tachycardia (n=6; cycle length, 400�60 ms), and atrial fibrillation (n=1). Ablation was successful in 73% of intra-atrial reentrant tachycardia, 75% of atrial flutter, and all focal atrial tachycardia and focal atrial fibrillation. During the follow-up period of 53�34 months, 2 patients were lost to follow-up, 3 died of heart failure, 2 underwent heart transplantation, and 1 underwent conduit replacement. Of the remaining group, 8 had sinus rhythm and 3 had SVT. Conclusions— Focal and reentrant mechanisms underlie postoperative SVT in patients with univentricular heart. Successive SVT developing over time may be caused by different mechanisms. Ablative therapy is potentially curative, with a procedural success rate of 78%. In patients who had multiple ablation procedures, the SVT originated from different atrial sites, suggesting that these new SVT were caused by progressive atrial disease. Despite recurrent SVT, sinus rhythm at the end of the follow-up period was achieved in 72%.


  • Reply

    by Peter Lukac, Vibeke E. Hjortdal, Peter S. Hansen

  • Open Access

    Prevention of Atrial Flutter With Cryoablation May Be Proarrhythmogenic

    by Peter Lukac, Vibeke E. Hjortdal, Anders K. Pedersen, Peter T. Mortensen, Henrik K. Jensen, Peter S. Hansen


  • Superior Transseptal Approach to Mitral Valve Is Associated With a Higher Need for Pacemaker Implantation Than the Left Atrial Approach

    by Peter Lukac, Vibeke E. Hjortdal, Anders K. Pedersen, Peter T. Mortensen, Henrik K. Jensen, Peter S. Hansen


  • The Superior Transseptal Surgical Approach to Mitral Valve Creates Slow Conduction

    by Peter Lukac, Vibeke Hjortdal, Anders K. Pedersen, Henrik K. Jensen, Peter T. Mortensen, Peter S. Hansen

    Background: Atrial tachycardia is very frequent after mitral valve surgery using the superior transseptal approach. Methods: Sixteen patients operated on for mitral valve disease (superior transseptal approach = Group A, n = 9, and left atrial approach = Group B, n = 7) underwent radiofrequency catheter ablation of atrial tachycardia guided by electroanatomic mapping. Twenty‐six consecutive patients without previous cardiac surgery with typical atrial flutter served as controls (Group C). Results: Atrial tachycardia occurred earlier after the operation in Group A than in Group B (median 97 vs 2,159 days, P = 0.003). Typical atrial flutter was the most frequent circuit in all groups (Group A—7 patients, Group B—5 patients, Group C—26 patients). Three patients in Group A developed right atrial incisional tachycardia. Ten of 14 tachycardia circuits (typical atrial flutter, n = 7, incisional tachycardia, n = 3) in Group A depended on the corridor between the right atrial part of the atriotomy and the tricuspid annulus. Slow conduction during typical atrial flutter was detected in this corridor in Group A, but not in the corresponding region in Groups B and C (P < 0.001). The cycle length of typical atrial flutter was longer in Groups A and B than in Group C (mean 283 ms and 282 ms vs 233 ms, P = 0.003). Patients in Group B with typical atrial flutter had larger right atria than patients in Group A or Group C (mean 156 mL vs 96 mL and 113 mL, P = 0.033). Conclusions: The superior transseptal incision may predispose to atrial tachycardia by creating slow conduction between the atriotomy and the tricuspid annulus.


  • Atrial Incision Affects the Incidence of Atrial Tachycardia After Mitral Valve Surgery

    by Peter Lukac, Vibeke E. Hjortdal, Anders K. Pedersen, Peter T. Mortensen, Henrik K. Jensen, Peter S. Hansen


  • Determination of Repetitive Slow Pathway Conduction for Evaluation of the Efficacy of Radiofrequency Ablation in AVNRT

    by Peter Lukac, Thomas A. Buckingham, Robert Hatala, Lubos Urban, Tibor Malacky, Peter Margitfalvi, Igor Riecansky

    LUKAC, P., et al.: Determination of Repetitive Slow Pathway Conduction for Evaluation of the Efficacy of Radiofrequency Ablation in AVNRT. Aims: To determine whether the loss of repetitive slow pathway conduction identifies a successful radiofrequency ablation of atrioventricular nodal reentry tachycardia (AVNRT). Methods and results: Thirty nine consecutive patients undergoing ablation of AVNRT using the slow pathway approach were included. At baseline and after each radiofrequency application with an episode of junctional rhythm, repetitive slow pathway conduction was assessed as follows: Effective refractory period of the fast pathway was determined. The coupling interval of the first atrial extrastimulus (A2) was set at 30 ms below the effective refractory period of the fast pathway to ensure its conduction via the slow pathway. The second atrial extrastimulus (A3) was introduced at progressively longer coupling intervals starting from 200 ms until: (1) it propagated to the His bundle or (2) an anterogradely blocked AV nodal echo of A2 appeared before a conducted A3 depolarized the atrium in the His bundle electrogram. The response was termed repetitive slow pathway conduction if A3 was conducted with an AH > 200 ms . Application was considered successful if no AVNRT could be induced. Repetitive slow pathway conduction was present after 1 of 39 successful and after 34 of 40 ineffective applications (P < 0.0001) . Repetitive slow pathway conduction identified a successful application with 97% sensitivity, 86% specificity, 86% positive predictive value, and 97% negative predictive value. Conclusion: The presence of repetitive slow pathway conduction identifies an unsuccessful application with a clinically meaningful negative predictive value. (PACE 2003; 26[Pt. I]:827–835)


    • 1 January 2001
      • Vol. 102  (9) , 390-9

    Endocrine activation in tachycardias.

    by P Lukac, S Lukacova, M Vigas, R Hatala

    This article reviews the complex character of neuroendocrine response to paroxysmal tachycardia. While the endocrine influences in arrhythmogenesis are well perceived by the cardiologists, less attention has been paid to influence of tachycardia on neuroendocrine activation. However, this may significantly alter the clinical course of tachycardias and its responses to pharmacotherapeutic interventions. Main characteristics of hormones with direct relationship to cardiovascular system (ANP, AVP, catecholamines, angiotensin and others) are listed with description of regulation of their secretion and main biological effects, especially with regard to regulation of circulation. Changes in hemodynamics during tachycardia with accompanying changes in ANP, AVP renin-angiotensin-aldosterone system, sympatho-neural and sympatho-adrenal activation are reviewed. Further research and understanding require more complex approach and concentration on interrelationship of different regulatory hormones in tachycardia. (Fig. 2, Ref. 96.)